Home Cart Sign in  
Chemical Structure| 1334526-14-5 Chemical Structure| 1334526-14-5

Structure of (±)-ML 209
CAS No.: 1334526-14-5

Chemical Structure| 1334526-14-5

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

(±)-ML 209 is a RORγt inverse agonist with IC50 of 460 nM.

Synonyms: ML-209

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

DE Stock

US Stock

Asia Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of (±)-ML 209

CAS No. :1334526-14-5
Formula : C25H31NO6
M.W : 441.52
SMILES Code : COC1=CC(OC)=C(C(O)=C1)C(C2=CC=C3OCOC3=C2)CC(N4C[C@@H](C[C@@H](C4)C)C)=O
Synonyms :
ML-209
MDL No. :MFCD30742939

Safety of (±)-ML 209

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319
Precautionary Statements:P501-P270-P264-P280-P302+P352-P337+P313-P305+P351+P338-P362+P364-P332+P313-P301+P312+P330

Isoform Comparison

Biological Activity

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT02740335 Significant Bleeding Risk Phase 3 Recruiting June 2021 -
NCT01777750 ST-elevation Myocardial Infarc... More >>tion Less << Not Applicable Active, not recruiting July 2017 Austria ... More >> Medical University of Vienna Vienna, Austria, 1090 Less <<

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.26mL

0.45mL

0.23mL

11.32mL

2.26mL

1.13mL

22.65mL

4.53mL

2.26mL

 

Historical Records

Categories